These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 18505308)

  • 1. An open-label, prospective study of repetitive transcranial magnetic stimulation (rTMS) in the long-term treatment of refractory depression: reproducibility and duration of the antidepressant effect in medication-free patients.
    Demirtas-Tatlidede A; Mechanic-Hamilton D; Press DZ; Pearlman C; Stern WM; Thall M; Pascual-Leone A
    J Clin Psychiatry; 2008 Jun; 69(6):930-4. PubMed ID: 18505308
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Health-related quality of life assessment in depression after low-frequency transcranial magnetic stimulation].
    Dumas R; Boyer L; Richieri R; Guedj E; Auquier P; Lançon C
    Encephale; 2014 Feb; 40(1):74-80. PubMed ID: 24091070
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of intermittent Theta Burst Stimulation (iTBS) and 10-Hz high-frequency repetitive transcranial magnetic stimulation (rTMS) in treatment-resistant unipolar depression: study protocol for a randomised controlled trial.
    Bulteau S; Sébille V; Fayet G; Thomas-Ollivier V; Deschamps T; Bonnin-Rivalland A; Laforgue E; Pichot A; Valrivière P; Auffray-Calvier E; Fortin J; Péréon Y; Vanelle JM; Sauvaget A
    Trials; 2017 Jan; 18(1):17. PubMed ID: 28086851
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low frequency (1-Hz), right prefrontal repetitive transcranial magnetic stimulation (rTMS) compared with venlafaxine ER in the treatment of resistant depression: a double-blind, single-centre, randomized study.
    Bares M; Kopecek M; Novak T; Stopkova P; Sos P; Kozeny J; Brunovsky M; Höschl C
    J Affect Disord; 2009 Nov; 118(1-3):94-100. PubMed ID: 19249105
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of Adults with Autism and Major Depressive Disorder Using Transcranial Magnetic Stimulation: An Open Label Pilot Study.
    Gwynette MF; Lowe DW; Henneberry EA; Sahlem GL; Wiley MG; Alsarraf H; Russo SB; Joseph JE; Summers PM; Lohnes L; George MS
    Autism Res; 2020 Mar; 13(3):346-351. PubMed ID: 31944611
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The clinical effectiveness and cost of repetitive transcranial magnetic stimulation versus electroconvulsive therapy in severe depression: a multicentre pragmatic randomised controlled trial and economic analysis.
    McLoughlin DM; Mogg A; Eranti S; Pluck G; Purvis R; Edwards D; Landau S; Brown R; Rabe-Heskith S; Howard R; Philpot M; Rothwell J; Romeo R; Knapp M
    Health Technol Assess; 2007 Jul; 11(24):1-54. PubMed ID: 17580003
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Shorter duration of depressive episode may predict response to repetitive transcranial magnetic stimulation.
    Holtzheimer PE; Russo J; Claypoole KH; Roy-Byrne P; Avery DH
    Depress Anxiety; 2004; 19(1):24-30. PubMed ID: 14978782
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Efficacy of repetitive transcranial magnetic stimulation (rTMS) in major depression: a review].
    Brunelin J; Poulet E; Boeuve C; Zeroug-vial H; d'Amato T; Saoud M
    Encephale; 2007; 33(2):126-34. PubMed ID: 17675907
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of repetitive transcranial magnetic stimulation on the Hamilton Depression Rating Scale-17 criterion in patients with major depressive disorder without psychotic features: a systematic review and meta-analysis of intervention studies.
    Hassanzadeh E; Moradi G; Arasteh M; Moradi Y
    BMC Psychol; 2024 Sep; 12(1):480. PubMed ID: 39256851
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of repetitive transcranial magnetic stimulation in the prevention of relapse of depression: study protocol for a randomized controlled trial.
    Wang H; Xue Y; Chen Y; Zhang R; Wang H; Zhang Y; Gan J; Zhang L; Tan Q
    Trials; 2013 Oct; 14():338. PubMed ID: 24135054
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulation of motor cortex excitability predicts antidepressant response to prefrontal cortex repetitive transcranial magnetic stimulation.
    Oliveira-Maia AJ; Press D; Pascual-Leone A
    Brain Stimul; 2017; 10(4):787-794. PubMed ID: 28438543
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effectiveness of theta burst versus high-frequency repetitive transcranial magnetic stimulation in patients with depression (THREE-D): a randomised non-inferiority trial.
    Blumberger DM; Vila-Rodriguez F; Thorpe KE; Feffer K; Noda Y; Giacobbe P; Knyahnytska Y; Kennedy SH; Lam RW; Daskalakis ZJ; Downar J
    Lancet; 2018 Apr; 391(10131):1683-1692. PubMed ID: 29726344
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy, Safety and Tolerability of Augmentative rTMS in Treatment of Major Depressive Disorder (MDD): A Prospective Cohort Study in Croatia.
    Filipcic I; Milovac Z; Sucic S; Gajsak T; Filipcic IS; Ivezic E; Aljinovic V; Orgulan I; Penic SZ; Bajic Z
    Psychiatr Danub; 2017 Mar; 29(1):31-38. PubMed ID: 28291972
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antidepressant effects of different schedules of repetitive transcranial magnetic stimulation vs. clomipramine in patients with major depression: relationship to changes in cortical excitability.
    Chistyakov AV; Kaplan B; Rubichek O; Kreinin I; Koren D; Feinsod M; Klein E
    Int J Neuropsychopharmacol; 2005 Jun; 8(2):223-33. PubMed ID: 15569397
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-frequency repetitive transcranial magnetic stimulation improves refractory depression by influencing catecholamine and brain-derived neurotrophic factors.
    Yukimasa T; Yoshimura R; Tamagawa A; Uozumi T; Shinkai K; Ueda N; Tsuji S; Nakamura J
    Pharmacopsychiatry; 2006 Mar; 39(2):52-9. PubMed ID: 16555165
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel Augmentation Strategies in Major Depression.
    Martiny K
    Dan Med J; 2017 Apr; 64(4):. PubMed ID: 28385173
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Repetitive transcranial magnetic stimulation versus electroconvulsive therapy for the treatment of major depressive disorder, a randomized controlled clinical trial.
    Keshtkar M; Ghanizadeh A; Firoozabadi A
    J ECT; 2011 Dec; 27(4):310-4. PubMed ID: 22080240
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Actigraphy in Patients With Major Depressive Disorder Undergoing Repetitive Transcranial Magnetic Stimulation: An Open Label Pilot Study.
    Nishida M; Kikuchi S; Nisijima K; Suda S
    J ECT; 2017 Mar; 33(1):36-42. PubMed ID: 27611301
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transcranial magnetic stimulation accelerates the antidepressant effect of amitriptyline in severe depression: a double-blind placebo-controlled study.
    Rumi DO; Gattaz WF; Rigonatti SP; Rosa MA; Fregni F; Rosa MO; Mansur C; Myczkowski ML; Moreno RA; Marcolin MA
    Biol Psychiatry; 2005 Jan; 57(2):162-6. PubMed ID: 15652875
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Repetitive transcranial magnetic stimulation: a putative add-on treatment for major depression in elderly patients.
    Mosimann UP; Schmitt W; Greenberg BD; Kosel M; Müri RM; Berkhoff M; Hess CW; Fisch HU; Schlaepfer TE
    Psychiatry Res; 2004 Apr; 126(2):123-33. PubMed ID: 15123391
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.